Laminate Medical Technologies announces enrollment of first patients in pivotal trial of the VasQ device

 

129 subjects will be enrolled in 13 centers around the US

TEL AVIV, Israel, Jan. 18, 2018 /PRNewswire/ -- Laminate Medical Technologies (Laminate), a privately-held start-up developing VasQ, an implanted blood vessel external support device for patients requiring arteriovenous fistula as vascular access for hemodialysis, today announced the launch of its FDA pivotal study in the US.

The first surgeries were performed by Dr. Jason Burgess and Dr. Paul Orland at the Carolinas Medical Center-Mercy, Charlotte, North Carolina.

"We are excited to be the first site that enrolled patients in the US. The device was easy to implant and I am happy with the surgical results. We are looking forward to evaluating the device's long term effect," said Burgess.

"The device was easy to handle and I was very happy with the postoperative results. This new technology is targeting the major problems of AVFs: maturation and long term longevity of the fistula," said Orland.

The prospective, multi-center, single-arm, open-label, 13-site study will enroll 129 male and female patients, 18 to 80 years old, who require creation of new brachiocephalic fistula. During screening, surgeons will assess additional eligibility criteria such as adequate blood vessel anatomy and absence of potentially precluding past and current medical conditions and comorbidities. The primary effectiveness endpoint for this trial will be the primary patency rate 6 months after creation of the arteriovenous fistula. Patients will be followed for a total of 2 years.

"The launch of this pivotal study marks an important step forward for VasQ in the US market and a promising milestone for patients with kidney failure. We were excited to see the high level of interest and support from our partner sites, when we offered them to participate in the study," said Laminate CEO Tammy Gilon.

Developed by Laminate, VasQ is intended for patients suffering from kidney failure and in need of dialysis, which requires vascular access. The most common and preferred method of vascular access is an arteriovenous fistula, created by surgically suturing a blood vessel connection between an artery and a vein, usually in the region of the wrist or the elbow. Two intravenous needles are inserted through the vein to remove the patient's blood for filtration in the dialysis machine, and then return it. This connection ensures a sufficiently high transfer of blood volume (veins do not transfer sufficient volume, while arteries are too deep for repeated insertion of a needle).

Unfortunately, a venous blockage forms in more than half of these cases. In response to increased pressure, the vein wall thickens, which in turn affects the blood flow during dialysis. As a result, the patient must have repeat interventions to save the fistula or, in cases where the fistula cannot be used, use other vascular access alternatives affecting the ability to receive dialysis and creating a burden on the hospital's resources.

VasQ is an external scaffold placed over the fistula, creating an optimal geometric configuration with the artery and reducing the tension in the vein. This allows proper blood flow during dialysis while reducing vein blockage created by thickening of the vein wall. Studies show VasQ has significant success. VasQ is a CE Marked device already in use in hospitals in Europe and in Israel, with impressive results.

About Laminate Medical Technologies

Laminate Medical Technologies was founded in 2012 by Tammy Gilon and Dr. Eyal Orion, who began their work in the Rad-Biomed incubator. Laminate has developed VasQ, a blood vessel support device for patients receiving dialysis. VasQ is CE Marked and used in hospitals in Europe and Israel.

To see a demonstration video of VasQ, go to https://www.youtube.com/watch?v=2W3HoTH2x58. Visit Laminate at www.laminatemedical.com.

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/laminate-medical-technologies-announces-enrollment-of-first-patients-in-pivotal-trial-of-the-vasq-device-300585008.html

SOURCE Laminate Medical Technologies



RELATED LINKS
http://www.laminatemedical.com

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos and customised feeds just for media.

View and download archived video content distributed by MultiVu on The Digital Center.

 

Get content for your website

Enhance your website's or blog's content with PR Newswire's customised real-time news feeds.
Start today.

 

 
 

Contact PR Newswire

Send us an email at info@prnewswire.co.il or call us at +972-77-2005042

 

 
 

Become a PR Newswire client

Send us an email at info@prnewswire.co.il or call us at +972-77-2005042

 

 
  1. Products & Services
  2. News Releases
  3. Contact Us